MarketPulse

equity offering

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Sol-Gel Raises $33.1M via Oversubscribed Offering to Advance Rare Disease Pipeline

Sol-Gel Technologies prices 459,112 shares at $72 each, raising $33.1M for SGT-610 development in Gorlin syndrome treatment.
SLGLPhase 3 clinical trialequity offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Dianthus Therapeutics Raises $625M in Upsized IPO Offering to Fund Pipeline Expansion

Dianthus Therapeutics prices $625M upsized offering at $81/share to fund drug development and commercial readiness. Closing expected March 12, 2026.
DNTHbiotechclinical-stage
GlobeNewswire Inc.GlobeNewswire Inc.··Alx Oncology Holdings Inc.

ALX Oncology Narrows Losses, Secures Funding as Clinical Pipeline Advances

ALX Oncology reduced losses and secured $150M in funding, extending cash runway to mid-2028. The company advances its clinical pipeline with CD47 biomarker validation for its cancer therapies.
ALXOclinical trialsevorpacept
BenzingaBenzinga··Lekha Gupta

JIADE Limited Launches $3M Direct Equity Offering

JIADE Limited launches $3M direct equity offering of 12M shares at $0.25 each. Stock fell 8.13% on announcement; potential $12M if all options exercised.
JDZGstock declineequity offering